These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31384240)

  • 1. Approach to Optimize Pharmacological Treatment in Children.
    Olguín HJ
    Dose Response; 2019; 17(3):1559325819863986. PubMed ID: 31384240
    [No Abstract]   [Full Text] [Related]  

  • 2. Principles of therapeutic drug monitoring.
    Zhao W; Jacqz-Aigrain E
    Handb Exp Pharmacol; 2011; 205():77-90. PubMed ID: 21882106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antituberculosis drugs in children.
    Schaaf HS; Garcia-Prats AJ; Donald PR
    Clin Pharmacol Ther; 2015 Sep; 98(3):252-65. PubMed ID: 26095192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
    Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
    Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring.
    Landmark CJ; Johannessen SI; Tomson T
    Epileptic Disord; 2016 Dec; 18(4):367-383. PubMed ID: 27965183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of therapeutic drug monitoring in pulmonary infections].
    Padoin C
    Rev Mal Respir; 2017 Jun; 34(6):693-705. PubMed ID: 28528008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
    Heffernan AJ; Sime FB; Taccone FS; Roberts JA
    Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis.
    Zuur MA; Bolhuis MS; Anthony R; den Hertog A; van der Laan T; Wilffert B; de Lange W; van Soolingen D; Alffenaar JW
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):509-21. PubMed ID: 26950189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients.
    Klupp J; Holt DW; van Gelder T
    Transpl Immunol; 2002 May; 9(2-4):211-4. PubMed ID: 12180833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic relevance of pharmacokinetics and pharmacodynamics.
    Ratain MJ
    Semin Oncol; 1992 Aug; 19(4 Suppl 11):8-13. PubMed ID: 1509284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer drug pharmacodynamics.
    Powis G
    Cancer Chemother Pharmacol; 1985; 14(3):177-83. PubMed ID: 3888428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients.
    John J; Loo A; Mazur S; Walsh TJ
    Expert Opin Drug Metab Toxicol; 2019 Nov; 15(11):881-895. PubMed ID: 31550939
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs.
    Danhof M; Mandema JW
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):516-9. PubMed ID: 1490817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.
    Tsai D; Lipman J; Roberts JA
    Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic considerations in pediatric pharmacotherapy.
    Lim SY; Pettit RS
    Am J Health Syst Pharm; 2019 Sep; 76(19):1472-1480. PubMed ID: 31532503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.
    Andrews LM; Li Y; De Winter BCM; Shi YY; Baan CC; Van Gelder T; Hesselink DA
    Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1225-1236. PubMed ID: 29084469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamics of anticancer agents].
    Ohtsu T; Sasaki Y
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1741-9. PubMed ID: 8379667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients.
    Albring A; Wendt L; Harz N; Engler H; Wilde B; Kribben A; Lindemann M; Schedlowski M; Witzke O
    Clin Transplant; 2015 Apr; 29(4):294-300. PubMed ID: 25557538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.